La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Interleukin-1 signaling pathway as a therapeutic target in transthyretin amyloidosis.

Identifieur interne : 000763 ( Main/Exploration ); précédent : 000762; suivant : 000764

Interleukin-1 signaling pathway as a therapeutic target in transthyretin amyloidosis.

Auteurs : Nádia Pereira Gonçalves [Portugal] ; Paulo Vieira [France] ; Maria João Saraiva [Portugal]

Source :

RBID : Hal:pasteur-01071597

English descriptors

Abstract

INTRODUCTION: Inflammation is a key pathological hallmark of several neurodegenerative disorders including Alzheimer's disease, Parkinson's disease and familial amyloidotic polyneuropathy (FAP). Among all inflammatory cytokines associated with FAP, IL-1β, in particular, has been implicated in playing a key pathogenic role. In the present study, we sought to investigate whether blocking IL-1β signaling provides disease-modifying benefits in an FAP mouse model. METHODS: We assessed the effect of chronic administration of Anakinra, an IL-1 antagonist, on FAP pathogenesis in vivo, using real-time polymerase chain reaction (qPCR), semi-quantitative immunohistochemistry (SQ-IHC), western blot and nerve morphometric analyses. RESULTS: We found that treatment with Anakinra prevents transthyretin (TTR) extracellular deposition in sciatic nerve, protecting unmyelinated nerve fibers from aggregate-induced degeneration. Moreover, Anakinra administration significantly suppressed IL-1 signaling pathway and inhibited apoptosis and nitrative stress. CONCLUSIONS: The present work highlights the relevance of the IL-1 signaling pathway in the pathophysiology of FAP. Our results bring to light the importance of non-amyloid targets in the therapeutic strategies for this disorder. Thus, we propose the use of Anakinra as a potential therapeutic agent for TTR-related amyloidosis.

Url:
DOI: 10.3109/13506129.2014.927759


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Interleukin-1 signaling pathway as a therapeutic target in transthyretin amyloidosis.</title>
<author>
<name sortKey="Goncalves, Nadia Pereira" sort="Goncalves, Nadia Pereira" uniqKey="Goncalves N" first="Nádia Pereira" last="Gonçalves">Nádia Pereira Gonçalves</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-268096" status="INCOMING">
<orgName>Department of Molecular Neurobiology</orgName>
<desc>
<address>
<addrLine>Rua do Campo Alegre, Porto</addrLine>
<country key="PT"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-305716" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-305716" type="direct">
<org type="institution" xml:id="struct-305716" status="INCOMING">
<orgName>Institute for Molecular and Cell Biology</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Portugal</country>
</affiliation>
</author>
<author>
<name sortKey="Vieira, Paulo" sort="Vieira, Paulo" uniqKey="Vieira P" first="Paulo" last="Vieira">Paulo Vieira</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-31466" status="OLD">
<orgName>Développement des Lymphocytes</orgName>
<desc>
<address>
<addrLine>25-28 rue du Docteur Roux F-75724 Paris Cedex 15</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation name="U668" active="#struct-303623" type="direct"></relation>
<relation active="#struct-300027" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle name="U668" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300027" type="direct">
<org type="institution" xml:id="struct-300027" status="VALID">
<idno type="IdRef">027936643</idno>
<idno type="ISNI">0000 0001 2353 6535</idno>
<orgName>Institut Pasteur [Paris]</orgName>
<desc>
<address>
<addrLine>25-28, rue du docteur Roux, 75724 Paris cedex 15</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.pasteur.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Saraiva, Maria Joao" sort="Saraiva, Maria Joao" uniqKey="Saraiva M" first="Maria João" last="Saraiva">Maria João Saraiva</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-268096" status="INCOMING">
<orgName>Department of Molecular Neurobiology</orgName>
<desc>
<address>
<addrLine>Rua do Campo Alegre, Porto</addrLine>
<country key="PT"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-305716" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-305716" type="direct">
<org type="institution" xml:id="struct-305716" status="INCOMING">
<orgName>Institute for Molecular and Cell Biology</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Portugal</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:pasteur-01071597</idno>
<idno type="halId">pasteur-01071597</idno>
<idno type="halUri">https://hal-pasteur.archives-ouvertes.fr/pasteur-01071597</idno>
<idno type="url">https://hal-pasteur.archives-ouvertes.fr/pasteur-01071597</idno>
<idno type="doi">10.3109/13506129.2014.927759</idno>
<date when="2014-09">2014-09</date>
<idno type="wicri:Area/Hal/Corpus">000584</idno>
<idno type="wicri:Area/Hal/Curation">000584</idno>
<idno type="wicri:Area/Hal/Checkpoint">000252</idno>
<idno type="wicri:explorRef" wicri:stream="Hal" wicri:step="Checkpoint">000252</idno>
<idno type="wicri:doubleKey">1350-6129:2014:Goncalves N:interleukin:signaling:pathway</idno>
<idno type="wicri:Area/Main/Merge">000766</idno>
<idno type="wicri:Area/Main/Curation">000763</idno>
<idno type="wicri:Area/Main/Exploration">000763</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Interleukin-1 signaling pathway as a therapeutic target in transthyretin amyloidosis.</title>
<author>
<name sortKey="Goncalves, Nadia Pereira" sort="Goncalves, Nadia Pereira" uniqKey="Goncalves N" first="Nádia Pereira" last="Gonçalves">Nádia Pereira Gonçalves</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-268096" status="INCOMING">
<orgName>Department of Molecular Neurobiology</orgName>
<desc>
<address>
<addrLine>Rua do Campo Alegre, Porto</addrLine>
<country key="PT"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-305716" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-305716" type="direct">
<org type="institution" xml:id="struct-305716" status="INCOMING">
<orgName>Institute for Molecular and Cell Biology</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Portugal</country>
</affiliation>
</author>
<author>
<name sortKey="Vieira, Paulo" sort="Vieira, Paulo" uniqKey="Vieira P" first="Paulo" last="Vieira">Paulo Vieira</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-31466" status="OLD">
<orgName>Développement des Lymphocytes</orgName>
<desc>
<address>
<addrLine>25-28 rue du Docteur Roux F-75724 Paris Cedex 15</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation name="U668" active="#struct-303623" type="direct"></relation>
<relation active="#struct-300027" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle name="U668" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300027" type="direct">
<org type="institution" xml:id="struct-300027" status="VALID">
<idno type="IdRef">027936643</idno>
<idno type="ISNI">0000 0001 2353 6535</idno>
<orgName>Institut Pasteur [Paris]</orgName>
<desc>
<address>
<addrLine>25-28, rue du docteur Roux, 75724 Paris cedex 15</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.pasteur.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Saraiva, Maria Joao" sort="Saraiva, Maria Joao" uniqKey="Saraiva M" first="Maria João" last="Saraiva">Maria João Saraiva</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-268096" status="INCOMING">
<orgName>Department of Molecular Neurobiology</orgName>
<desc>
<address>
<addrLine>Rua do Campo Alegre, Porto</addrLine>
<country key="PT"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-305716" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-305716" type="direct">
<org type="institution" xml:id="struct-305716" status="INCOMING">
<orgName>Institute for Molecular and Cell Biology</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Portugal</country>
</affiliation>
</author>
</analytic>
<idno type="DOI">10.3109/13506129.2014.927759</idno>
<series>
<title level="j">Amyloid</title>
<idno type="ISSN">1350-6129</idno>
<imprint>
<date type="datePub">2014-09</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="mix" xml:lang="en">
<term>Anakinra</term>
<term>cytokines</term>
<term>familial amyloidotic</term>
<term>neurodegeneration</term>
<term>neuroinflammation</term>
<term>peripheral nervous system</term>
<term>polyneuropathy</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">INTRODUCTION: Inflammation is a key pathological hallmark of several neurodegenerative disorders including Alzheimer's disease, Parkinson's disease and familial amyloidotic polyneuropathy (FAP). Among all inflammatory cytokines associated with FAP, IL-1β, in particular, has been implicated in playing a key pathogenic role. In the present study, we sought to investigate whether blocking IL-1β signaling provides disease-modifying benefits in an FAP mouse model. METHODS: We assessed the effect of chronic administration of Anakinra, an IL-1 antagonist, on FAP pathogenesis in vivo, using real-time polymerase chain reaction (qPCR), semi-quantitative immunohistochemistry (SQ-IHC), western blot and nerve morphometric analyses. RESULTS: We found that treatment with Anakinra prevents transthyretin (TTR) extracellular deposition in sciatic nerve, protecting unmyelinated nerve fibers from aggregate-induced degeneration. Moreover, Anakinra administration significantly suppressed IL-1 signaling pathway and inhibited apoptosis and nitrative stress. CONCLUSIONS: The present work highlights the relevance of the IL-1 signaling pathway in the pathophysiology of FAP. Our results bring to light the importance of non-amyloid targets in the therapeutic strategies for this disorder. Thus, we propose the use of Anakinra as a potential therapeutic agent for TTR-related amyloidosis.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
<li>Portugal</li>
</country>
</list>
<tree>
<country name="Portugal">
<noRegion>
<name sortKey="Goncalves, Nadia Pereira" sort="Goncalves, Nadia Pereira" uniqKey="Goncalves N" first="Nádia Pereira" last="Gonçalves">Nádia Pereira Gonçalves</name>
</noRegion>
<name sortKey="Saraiva, Maria Joao" sort="Saraiva, Maria Joao" uniqKey="Saraiva M" first="Maria João" last="Saraiva">Maria João Saraiva</name>
</country>
<country name="France">
<noRegion>
<name sortKey="Vieira, Paulo" sort="Vieira, Paulo" uniqKey="Vieira P" first="Paulo" last="Vieira">Paulo Vieira</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000763 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000763 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Hal:pasteur-01071597
   |texte=   Interleukin-1 signaling pathway as a therapeutic target in transthyretin amyloidosis.
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024